We report on the use of three ''cold'' atmosphericplasma(CAP) devices in treating model nails that have been coated on the backsideofthe nail with either Escherichia coli (E. coli)bacteria or Trichophyton rubrum (T. rubrum)f ungus. We tested ah elium plasma jet; as urface microdischarge plasma device; and afl oating electrode dielectric barrierd ischarge. All of the devices, acting through themodel nail, showed significant log reductions of bacterial and fungalt argets in several tens of minutes. CAP technology appears to offer promise as as afe, effective, and inexpensive therapy for fungal nail infection treatment.
Introduction
Onychomycosisorfungal nail is acommon fungal infection of the toenail or fingernail with significant barriers to successfult reatment. [1] An imageo fh umant oe nails witho nychomycosis is showni nF igure 1(a).I ti st he most commonly diagnosed andt reatedd iseaseb y podiatrists. [2] Thep revalence of onychomycosis is estimated to affect 10% of the world's adult population andasmanyas38million people in the United States. [1] The incidence of onychomycosis hasb een increasing, particularly among thee lderly and patientsw ith compromised immunes ystems. [3] It ise stimatedt hat $30%o fd iabeticsa nd $50% of people over 70 have onychomycosis.
Typical symptomso fo nychomycosis include nail discoloration,t hickening, brittleness, and in laters tages, possibly nail detachment. These are mainly cosmetic problems, but there are more serious consequences as well, includingp ain and ar eduction in the patient's mobility. These symptoms can haveasignificant adverse effect on quality of life. Patientswith other diseases run additional risks if they contract onychomycosis. For example, effective treatment of onychomycosis can be important for diabetics. In these patients, fungalinfections can lead to foot ulcers and secondary bacterial infections, possibly leadingt o lower limb amputation. [4] Finally, the growing problems associated with antimicrobial resistance have begun to limit the effectiveness of some drugsu sed for infectious disease control, promptingt he searchf or medical device alternatives. [5] Among fungal strains associatedw ith onychomycosis, Trichophyton rubrum (T. rubrum)r epresents the most clinically important species. Ita ccountsf or $80% of all dermatophytoses in humans. [6] [7] [8] Current onychomycosis treatment options include various home remedies,topical creams, oral drugs, and laser treatments. These conventional approaches, however, are characterized by limited success, unsafeside effects,high costs, and prolonged time course requiredfor treatment. Treatment of onychomycosis is challenging because the infection is embedded underneath or within the nail and is difficultt or each with the above-listed methods. [9] Physicalt echniques, includings urgical removal, nail abrasion, or thinning are often performed in conjunction with topical treatment. However, these physicaltechniques can result in considerable patient discomfort,i ncreased costs, and may result in subsequent infection.
Systemic oral therapy is the mainstay of treatment due to the generally poor permeability of the nail plate to topically applied drugs. Systemic orals yield cure rates ranging from 17 to 38%, [10] but require frequent blood tests for hepatic monitoring and are frequently associated with various adverser eactions, drug-drug interactions and toxicities due to the doses required to concentrate therapy at the actual site of infection. Topical therapyo fn ail disease is desirable to avoid the side effects associated with systemic therapy, to increase patient compliance and to reduce the cost of treatment. However,c urrent topical drugs require daily applications over the courseofayear, and have a17% or less chance of success. Until the recent introduction of better performing topical creams, FDA-approved topical treatment yields historically had cure rates of only 5.5-8.5% after ayear of treatment. [11] [12] [13] Lasert reatment is relativelyc ostly and currently lacks adequate clinical data to determine efficacy rates. The US Food and Drug Administration (FDA) has allowed the devicest ob em arketed for ''temporary increase in clear nail'' only. Ap ublished studyu sing aN d:YAG 1064 nm laser showeds ome fungicidale ffects in suspension, but an in vivo treatment of toenails showed no improvement in Onychomycosis Severity Index Scores. [14] It would be advantageous to have am edical device that delivers topicalt herapy directly to thes iteo f infection. In this article, we report on theu se of three non-thermalo r' 'cold''a tmospheric plasma (CAP) devices in treating modeln ails withe ither E. coli bacteria or T. rubrum fungus appliedtothe nail surface. Theprimary goal of this studyi st od emonstratet he effectiveness of variousp lasmad evicesi nt reatingf ungali nfections of then ail, andt he modelf ungal organismsw ec hose to study, namely T. rubrum,i sk nown to be thep rimary cause ($ 80%) of human fungal nail infections. Experiments with E. coli served to help connectt he results of thep resent experimentsw ithp reviousp lasmad isinfections tudies that employed bacterialt argets.P lasmae xposure wast estedw ith microbialc ontamination on botht he nail backside as well as thet opside (i.e.,d irectly exposedt op lasma) in ordert os how most clearlyt he effectso ft he nail barriero na ntimicrobial kinetics of the plasma devices. Thet hree plasma devicest esteda re operated in ar ooma ir environment: Helium (He)p lasmaj et; surfacem icrodischarge (SMD); and floatinge lectroded ielectricb arrierd ischarge (FE-DBD).A fter summarizing recent progress in plasma biomedicine, we describe thed evicesa nd model nail treatmentp rotocols.T henw es ummarizet he effectiveness of each of these approaches andc oncludew ithr ecommendationsf or future studiesa nd ac omment on the future prospectso ft hist echnology.
Plasma Treatment of Onychomycosis
The use of CAP for various biomedical applications is now welle stablished,a nd several devices have been tested in animal and evenhuman trials. [15] [16] [17] [18] Numerous examples have been reported, including treatingd ental infections; various dermatological applications; promoting wound sterilization,h ealinga nd bleeding cessation; and cancer treatment, among others. [19] [20] [21] [22] [23] Von Woedtke at al. report that three clinical trials of CAP devices havebeen conducted in Germany and two CAP devices received CE marking in Europe( equivalent to FDA device approval in the USA) in 2013, bothfor treating skin wounds and ulcers. [17] Traditional plasma-basedelectrosurgical ''ablation''devices have been used commercially fors everald ecadesf or tissue cutting, coagulation, dessication,a nd cauterization. [24] [25] [26] [27] Plasma ablationdevicesoperatemanly viatissueheating; the effectsare thereforeprimarily thermal.CAP,alsoreferred to as ''low temperaturep lasma,'' by contrast, transfers littleheatand the effectsare primarily non-thermal.
CAP devices generally use either rare gas (He, Ne, or Ar) jets in air or some type of dielectric barrierdischargeinair. CAP-generating devicesh ave been shownt or eadily kill bacteria, viruses, and fungi both on surfaces and in aqueous solution. The microbialk illing mechanismsa re not fully understood, but are generally thoughtt ob ea ssociated with reactive chemical species; photons; electric fields;and electrical charge. Recent studies reporting the use of CAP for skin treatments, skin disinfection,and related applications. [28] [29] [30] [31] [32] [33] Reactive plasma species, at the moderatec oncentrations and doses found in non-thermalp lasma streams, appear to cause little to no permanent damage to living tissue, while being capable of efficiently destroyingmicrobial cells. This ability of plasma to destroy microbes without significantly damaging tissue is central to the success of plasma applications in medicine for both decontamination and disinfection. There is currently one report of ac linical trial investigatingp lasma treatment of onychomycosis. [34] However, to the authors' knowledge, this is the first report on the application of CAP to treat onychomycosis in the current scientific literature.
Experimental System and Procedures
Human nails are relatively expensive and are not well suited for properexperimental testing of plasma devices. For example, human cadaver nails come in differents izes, curvatures, and thicknesses that limitthe ability to compare instrument modification results from experiment to experiment. Therefore, we used bovine hoof slices as as urrogate model for the human toe nail. Bovine hoof is aw ell-recognized and tested surrogate for human nails. [35] In addition to being cost effective, bovine hoof has the advantage that it can be slicedtoaconsistent size and thickness. Bovine hooves were obtainedf rom al ocal butcher and soaked in water over 24 htofacilitatetheir cutting(via microtome) into thin slices. Slices rangedi nt hicknessf rom 0.2-0.3 mm for the anti-microbial experiments. Slices werep unched out (Ø ¼ 29 mm) and dried at room temperature before being stored ( Figure 1b ).T he hoof slice thicknessm atched the lower range of healthy human nail plates, which typically vary from 0.5 to 1.0 mm at their distal edge. The individual hoof slice samples are typically sealeda tt he edges using clay in order to eliminatet he possibility of gas leakage around the edge (cf.Figure1c). Figure 2 (a)s howsamodified Franz cell, ao ne-chamber diffusionchamber commonly used in topical drug experiments for nails, with amounted hoof slice. When the hoof slice is mounted, the top hoofsurface is open to the air and the bottom surface residesw ithin an O-ring sealed chamber. In other experiments, we sealed the edges of the hoof disc with clay, as noted above and as showni n Figure 1 (c). For anti-microbial experiments, viable microorganisms were spread on the bottom surface of the hoof, which was enclosed in the sealedc hamber within the holder. Plasma in various forms was applied to the exposed top of the bovine hoof slice with edges fully sealed. Consequently, the antifungal plasma had to penetrate through the keratin barrier to access and kill the microorganism. In some cases, experiments were performed with microorganisms spread on the top of the hoof disc as well. It is well knownt hat plasma can kill microorganisms that are on surfaces of various materials. The major result of the present paper is to describe the effects of plasma actingt hrought he nail material and so we emphasize the through-nail results here.
The flow charto ft he treatment protocol is showni n Figure 2 (b). Details of the experimental procedure is given in the following paragraphs.
The bacterial experiments used the common Escherichia coli bacterial species E. coli K12, which was cultured and prepared as described previously. [36] Bacteria were growni nl ysogeny broth( LB) medium to OD 600 ¼ 1c orresponding to approximately5 Ã 10 8 colony-forming units per ml (cfu ml
À1
). Suspensionso fE. coli were pelleted in 150 mlaliquots by centrifugation at 5000rpm. E. coli were dried on hoof discs in preparation for exposuretoplasma. The bacteria were spread to ad iameter of approximately 1cmi nt he center of the disc. Prior to adding bacteria to the discs, the discs were washed with sterile watert hat was allowed to evaporate completelyf rom the surface of the disc. To seed the discs with bacteria, pellets of E. coli were spread with ap lastic inoculatingl oop. The discs were allowed to dry in as terile environmentu ntil the surface of the discs was no longer visibly wet and additional dryingtime did not result in any change in the appearance of the surface. This drying procedure did not significantly affect the bacteria viability.Once the surface was dry, the hoof discs wereready for plasma treatment.
Fungal experiments used T. rubrum as noted above. The source of T. rubrum was AmericanType CultureCollection (Manassas, VA) listed as T. rubrum (Castellani) Sabouraud, anamorph (ATCC 1 MYA-3108). To obtain al iving culture for our studies, T. rubrum fungusw as grown on petri dishesc ontainingE mmon's modified Sabouraud medium agar (Spectrum Labs) and grown at 28 8C. Growthcontinued for 7-10 du ntil the dishes were confluent.T he fungal cells (conidia and mycelia) were harvested by scraping and homogenously re-suspending in sterile phosphate buffered saline (PBS). For each bovine hoof slice tested, 100 mla liquots of fungal culture were withdrawn and pipetted onto one side of the bovine hoof slice surface and stored in asterile environmentuntil dry (about 2h). As with the bacterial inoculation, the fungusw as spreadt oa diameter of approximately 1cma tt he center of the disc. The direct killing experiments involved placing the fungal (or bacterial) contaminated hoof within 5mmo f the plasma efflux, directly exposingt he contaminated side.
To quantitate fungal (T. rubrum)killing after plasma treatment, each hoofw as placed in ac ontainer with 10 ml PBS and vortexed for 10 min to washt he fungal cells from the hoof surface. The resulting wash solution was serially diluted (five 10Â dilutions)i nto sterile PBS. To culture and colony count, 10 ml of each diluted solution was plated onto media agar plates (Emmons' modification of Sabouraud's agar, ATCC 1 Medium 28) and placed into a2 8 8 Ci ncubator. Each plating was done in triplicate.
The count and calculation of treatment results was performed after typically 7-10d incubation. Bacterial (E. coli)e xperiments were completed in the same way with the exceptions that cultures were grown at 37 8C overnight and LB media and agar plates were used. Counting colony-forming units (CFU)q uantified fungal and bacterial reduction by revealing the number of viable cells remaining after plasma treatment. We measure disinfection (the anti-microbial effect of each treatment) by calculating both the% reduction and the logarithmic (log) reduction factor (RF) usingt he following formula: RF ¼ log 10 (CFU untreatedplate ) À log 10 (CFU treated plate ). A1log reductionm eans that 90% of the cells werei nactivated and a2log reduction corresponds to a99% kill.
Three different plasma devices were tested in this study. The first devicei saHelium (He) plasma jet operated in He with 0.5% O 2 ,a si llustrated in Figure 3 . Figure 3 (a) is ap hotograph of the devices howing the plasma plume contacting ah uman fingern ail and Figure 3 (b) shows a schematicofthe treatment using sliced hoof disc. The gas enters as yringe with aq uartz tube inside.T he quartz tube is 4mmi nd iameter. Inside the tube is the electrode (copper wire 1mmi nd iameter),p owered by af unction generator( Protek 9301) with ah igh voltage amplifier (Trek 10/40A). The peak voltage was 8kV, approximately simusoidal, at af requency of 4kHz. The gas flow is 3Lmin
,t he separation between the tip of the syringe and the hoof surface is 5mm. The spatial extent of the antibacterial effects of the He plasma jet is significantly largert han the 1cmd iameter of the microbial samples used here. [37] The secondd evice tested is the surface microdischarge (SMD) plasma, shown in Figure 4 (a) (photograph) and 4(b) (schematic). The power supply and conditions are similar to those describedabove for the plasma jet (2.5 kV; $25 kHZ; and 5mms eparation between grounded mesh and hoof surface). This device is operated in room air. More details aboutthis device can be found elsewhere. [36, 38] The third device is similar to the SMD, but it is operated in the floatinge lectrode-DBD mode by eliminating the groundedmesh and allowing microfilament dischargesto directly contact the hoof disc. The power supply was operated at about 6kVatafrequency of about4kHz, with a separation of about1 mm in room air. In this case, a discharge will not be established unlessthe backsideofthe hoof disc is in contact with ag rounded surface. We employed ametalplate with the diameter of 1.5 cm for this purpose. Of course, the bacteria or fungus on the backside of the disc will be in contact witht he ground plate and this could affect the measured antimicrobial actionsofthe plasma. The metal plate and hoof disc were therefore washedtogether after FE-DBD treatment for both the treatedand the control cases. Figure 5 (a) is ap hotograph of aF E-DBD device contacting afi ngernail and Figure 5(b) is the corresponding schematic diagramfor the hoof disc treatment. Figure 6s hows results of E. coli killing on the backside of a0 .2-0.3 mm thick hoof disc for 5, 10, and 20 min exposures by the He jet device. The log reduction at 5a nd 10 min was about 1a nd at 20 min of exposure, this increasedt oalog reduction of about2 . By contrast,a bout 3l og reduction was observed witht he jet in direct contact with the bacteria on the topsideo f hoof disc (facing the jet) for this 20 min exposure. Figure 7s howsb acterial kill rates using the SMD device for exposures of 5, 10, and 20 min. These results are approximately the same as for the He jet case showed in Figure 6 . The SMD device appeared to be somewhat more effective than the He plasma jet in topside killing. For higher exposure times (10 or 20 min), virtually all the bacteria were killed whent he bacteria were on the topsideofthe hoof near the SMD electrode. These topside resultso nk eratin surfaces are consistentw ith previous work, [36] and are of course much faster than the anti-microbial results on the backside. Figure 8s hows results for FE-DBD exposure, similar to Figures6and7f or the other two devices.The approximately 4log reductionsf or 5a nd 10 min exposures and about 6log reduction for 20 min exposure are clearlyh igher than the results for the He jet or the SMD device. We also tested the topside antibacterial effect of FE-DBD and these are similar to the helium jet and SMD device results for topside disinfection. Figure 9s hows the log reductions for SMD applied to the hoofd iscs with T. rubrum fungus targets on the back of the hoof disc. The trends are similar to the results observed against an E. coli target, but the observed kill rates are slower. For example, Figure 7shows effectiveness against E. coli is $2log reduction after 20 min exposure whereas it is about one log reductiona gainst T. rubrum for the same time of exposure. This was also observed in the topside killing results: al og reduction of about2was observed against T. rubrum usingt he SMD for 10 min for fungus on the exposed (top) surface. However, the corresponding result for E. coli showed greater than 7log reduction. Figure 10 showst he effects of the FE-DBD device for 5, 10, and 20 min on T. rubrum on the backside of the hoof disc. The reasonf or the apparently lower log reduction for the intermediate exposure time of 10 min is not known, but some statistical variation was always observed in the log reduction numbers. Once again,t he FE-DBD results showed significantlyh igher kill rates for the T. rubrum,a si td id for the E. coli targets. Figure 11 (a) and (b) summarize the log reductions of E. coli and T. rubrum corresponding to the three devices, respectively. About 2log reduction was observed for He jet and SMD and about 6log reductionf or the FE-DBD against bacteria (E. coli). The 5min FE-DBD treatment against fungus (T. rubrum)i sc learly superior to the other two with up to 45 min exposure. Theseresults show that FE-DBD can clearly be more effective than the other two devices, but we note there are several limitations and issues with operating the FE-DBD device. These are discussed in the followingsection.
Results

Discussion
The results presentedh ere show that all three of the plasma devices tested: He plasma jet, the SMD device and the air-operated FE-DBD device were all capable of significantr ates of killing both the bacterial targeta nd the fungal target on the bovine hoof discs used as akeratin barrier model for ah umann ail. The observationso f killing rates for the bacterial target and the fungal target were qualitatively similar, but the bacterial targets were generally killed faster.A ll of the tests showed significant statistical variations, but this general trend was consistent over the entire study. Table 1lists some published surface disinfection results on exposed surfacesu sing air SMD as reportedb yo ther groupsa nd from our previous work. The model keratin surface is plasma-disinfected at rates similar to other, non-skin surfaces.
It is apparentfrom anumber of the sets of results we present that there were sometimes variations between results that were not internally consistent. For example, Figure 10 shows, counterintuitively, that the 10-min FE-DBD exposure of the hoof disc with T. rubrum present showed less killing than the 5-min exposure. We note that direct killing experiments (not shown here) did not show inconsistencies like this. We concluded that the most likely explanation is variation between hoof discs. We made significant efforts to obtain and process the model hoofd iscs (e.g., slicing and sanding to obtain the same thicknesses) as consistently and repeatedly as possible. However, these natural materialsa re inherently variable and it proved difficultt om ake the samples sufficiently identical that the killing ratess howed all of the expected trends. This no doubt reflects the nature of human nail materiala s well, so perhaps this characteristic of inherent material variability is to be expected and must be dealt with in any future human patient applications as well.
The SMD and He jet were approximately equally effective in antimicrobial action even though the devices are significantly different in the way they operate. The He jet is known to involve charged species, currents,and fields at the treated surface but the SMD device does not -o nly neutral reactive species diffuse from the SMD plasma zone to the treated surface. This result is surprising unless the anti-microbial action for each device is solely due to reactive species that diffuse through the nail material to attack the microorganism on the backside of the nail barrier. The floating electrode dielectric barrier discharge device (FE-DBD) showed significantly better resultsc ompared to the other devices,f or the cases we report here. Stainless steel E. coli 5min 4-5 [36] Silicone rubber E. coli 5min 4-5 [36] Silicon surface E. coli 5min 4-5 [36] Pig skin E. coli 5min 2 [ 36] Pig skin E. coli 6min 4 [ 29] Bovine hoof E. coli 5min $4T his paper Bovine hoof T. rubrum 5min 2T his paper For example, Figure 11 demonstrates the measured log reductions using all three devicesagainst E. coli (bacteria) and T. rubrum (fungus) on the backside of the discs. The FE-DBD device showed an average of about 6log reduction against E. coli whereast he other two devices showed only 2log reductions on average. The corresponding comparison for T. rubrum treatment is even more striking. For the cases we show here, the FE-DBD device achieved an average of 6log reductions after only 5min exposure while the other two devices achieved an average of under 2logs after 45 min. One possible explanationf or the difference in effectiveness compared to the other devices is that the FE-DBD probably delivers to the surface more reactive species, charges, currents, and as tronger electric fieldinthe filamentary discharges that characterize the FE-DBD. More definitivem echanistic studies will need to be conducted to clearly identify why the different devices show the effectiveness patternsthat are observed. However, regardless of the mechanismsinvolved, there are several importantc aveats that should be kept in mind when interpreting these data.C onsiderable efforts were made to be sure the samples were prepared as consistently as possible, but in some cases, results showed that the hoof disc in question was somehow damaged during sample preparation, so the sample was rejected. For example,i nF igure 11, the data denoted N ¼ 10 and showing as tandard deviationo fa bout 1log reductiona s indicated by themagnitudeofthe error bar, represents in fact 30 experiments. Each set of data represents three measurementsf or each of the N sets reported.I ts hould also be noted that problems withs ealing around the edges of the discs sometimes occurredb ut was easily detected because the log reductions wouldb em uch greater in those cases and not at all consistent with other measurements from the same set of hoof discs. We conclude that the data reportedh ere are generally reliable but clearlym ore needs to be done to more completely characterize these model nail materials in future studies. For example, we did not systematically image the disc materials with microscopy before use, and the spectroscopicm easurements we made were only preliminary.
The second point that is importantt ok eep in mind when comparing resultsfrom the different devices is that approximately 50% of the samples that were treated with our FE-DBD device were damaged sufficiently during processing that the samples had to be discarded. The results we present in this paper were the successful tests for which no significant damage was observed. We notethat separate tests of sample temperature rise during FE-DBD treatment showed that even after the longest exposures, temperature rise was within 5 8C. Separate experiments (not shown) demonstrate thatt his small rise in temperature did not cause the change in killing rate. We conclude that temperature rise is therefore not responsible for the higherkilling rates observed withthe FE-DBD device.
We tentatively attribute the problems observed with some of the FE-DBD exposure experiments to several characteristics of our FE-DBD device applied to nail material. First, we note that nail materiali sn ot flat,a nd therefore the distance between the flat dielectric surface of the device and the nail surface varies from point to point.T his appears to sometimes affect the distribution of current-carrying filaments that originate on the DBD surface and travel to and through the nail. Using the FE-DBD, current flows through the nail to ab acking conducting plate and the individual filamentary currents cannot be easily controlledw ith the plasma device and power supply we used in these experiments. It was sometimes observed that as mall hole would appear at some point on the disc during these damaging FE-DBD treatment,l eading to af ocusingo ft he current in that location and subsequent macroscopich ole formation. From the point of view of therapeutic applications of plasma devices for treating onychomycosis especially on inherently non-smooth nail surfaces, the FE-DBD devices need to be better controlledtoavoid damagingthe target nail. Nanosecondpulsed power supplies(e.g., apulsed-DC configuration)m ight be beneficial for better FE-DBD control. Damage to the discs was never observed when using either the He jet or the SMD device. They were generally less effective but muchsafer.
Finally, there is theq uestion of the possiblem echanismsl eadingt ob ackside killing of bacteriao rf ungus using the plasma devices. We note that the electrical field created at the nail surface by the FE-DBD device, andp ossiblys omep lasma jets, mayc ontribute to their antimicrobiale ffect.Aseparate study is underwayt o developamathematicalm odel fort he effects of the SMDd evicef or which there aren od irect plasma( or current) effects occurring during treatment. In the case of the SMD, the killing mechanism seems likely to be due to diffusion of reactive species created in the plasma through the porousn ail material to attack the underlyingmicroorganisms. FTIR measurements suggest that nitrogeno xide species (e.g., NO 2 )a re present in significant concentrations under thec onditions we used, and the well knowna ntimicrobiale ffects of these speciesm ay be playing ak ey role in thee ffects we observedi nt he present study. These results will be presented separately, but briefly, the analysis suggests that it is indeedl ikelyt hatd iffusion of knownp lasmageneratedr eactive species such as NO 2 ared iffusing through the nail material to reach the backside of thet arget. We notet hat the complexity of the natural keratinn ail materialc oupled with complex plasma chemistrym akes this analysisd ifficulta nd we expect that considerablef uturer esearch willb en eeded to Plasma Treatmento fO nychomycosis Plasma Process.P olym. 2016, 13,5 88-597 ß 2016 WILEY-VCHV erlag GmbH &C o. KGaA,W einheim significantly advance ourt heoreticalu nderstandingo f plasma treatmento fo nychomycosis.
Conclusion
Atmospheric pressure plasma devices have been shown to be effective in killing both E. coli bacteria and T. rubrum fungusa cting through model nail material made from sliced bovineh oofs. AH ep lasma jet, as urface microdischarge device( SMD) operating in air, and afl oating electrode -d ielectric barrier discharge (FE-DBD)d evice operated in air were compared in the study. The bacterial target was killed considerably faster than the fungal target, as expected. The He plasma jet and air SMD device were comparably effective in killing both bacteria and fungus through the model nail material. The FE-DBD device proved considerably more effective than the other two devices but it was more difficult to control. The difficulty to control the FE-DBDdevice led to numerous instancesofdamaged nails and suggests that better-engineered FE-DBD devices and possibly improved power suppliesare needed. Temperature measurements of the FE-DBD treated samplesshowed that the higher kill rates with FE-DBD were not due to plasmainduced heating.
The prospectsf or future clinical applications of plasma devices to treat humano nychomycosis seem promising. Three different plasma devices, operating in open air, were shownt ob er easonably effective. Plasma devices are relatively safe, simple, inexpensive,a nd fast acting as compared to the alternative therapies for onychomycosis. The present results suggest that there is alikely future for the use of plasma to treat this serious and widespread affliction.
